Delivery Order SPE2DB20D2014-SPE2DB25FC55T
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $15,524.10 firm fixed-price delivery order is for ISONIAZID 100 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a significant $999,999,999.00 Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,248.27, is for the delivery of ISONIAZID 300 MG TABLET 100S, a medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about major subcontractors. This delivery...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $5,584.64 and covers the procurement of 4567383306 Isoniazid 100mg Tablets, with a period of performance through March 25, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,470.84 for the delivery of ISONIAZID 300 MG TABLET 30S. It is a Firm Fixed Price contract with an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of ISONIAZID 300 MG TABLET 100S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,651.23 and an ultimate completion date of May 28, 2025. The contract is not set aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in SAM.gov and serves as a critical supplier of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Isosorbide Mononitrate 120 mg tablets (100-count unit) with a ceiling value of $1,384.36. This is a firm fixed-price delivery order executed under a non-competitive set-aside arrangement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor, particularly for military and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $753 to Amerisourcebergen Drug Corporation for 50 mg/5 ml isoniazid solution. As the prime contractor, Amerisourcebergen will deliver approximately 473 ml of the pharmaceutical product to a location in Conshohocken, Pennsylvania by July 3, 2023 in support of Defense Logistics Agency procurement programs. The order was placed under an existing DLA contract vehicle and no subcontractors or set aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,313.95 to AmerisourceBergen Drug Corp for the supply of Isosorbide Dinitrate 40 mg tablets (100-count units). This firm fixed-price delivery order, awarded on July 18, 2025, was completed by July 21, 2025, with no set-aside designation applied. The award utilizes a competitive procurement process, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical supply requirements. Performance of this...
- The Defense Logistics Agency awarded a $3,992.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ivabradine HCl 5 mg tablets (60-count). This non-set-aside contract is scheduled for completion by August 1, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Isosorbide Mononitrate 10 mg tablets (100 count) valued at $1,128.63. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 6, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC55TDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,193.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Isoniazid 300 mg tablets in quantities of 30. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of July 25, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The contract supports critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/24/25 |